A股異動丨中航三鑫一字板 實控人擬變更為海南控股
格隆匯12月27日丨中航三鑫(002163.SZ)一字板,報5.16元,總市值41.5億元。

中航三鑫昨晚公告稱,控股股東航空工業通飛及其下屬子公司貴州航空、深圳貴航擬以非公開協議的方式向海南控股轉讓其合計持有的公司不超過2.2億股無限售條件流通股股份(佔公司總股本的27.38%),本次股份轉讓完成後將導致公司控制權發生變化。公司將從央企系列降級到地方國資系列。
據海南控股官網顯示,該公司由海南省國資委100%持股,是海南省政府為了引進大項目,帶動省外資金投資海南,推進省內重大項目實施,促進海南經濟發展而設立的綜合性投資控股公司。截至2019年8月31日,該公司投資的下屬企業共計114家。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.